Weighted 10-year survival and neurological outcomes after zone 2 thoracic endovascular aortic repair for acute type B aortic dissection
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2025.05.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Zhongze Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Acad…. Hauptthemen laut MEDLINE: Aortic Dissection, Endovascular Procedures, Aortic Aneurysm, Thoracic, Blood Vessel Prosthesis Implantation. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: The long-term benefits of left subclavian artery (LSA) revascularization during thoracic endovascular aortic repair (TEVAR) for patients with acute type B aortic dissection (aTBAD) remain controversial. This study aimed to evaluate the impact of LSA revascularization during TEVAR on short- and long-term survival and neurologic outcomes in patients with aTBAD. METHODS: We retrospectively analyzed data from consecutive patients with aTBAD undergoing zone 2 TEVAR between 2010 and 2020 at one Chinese national aortic center. Inverse probability of treatment weighting was employed to mitigate baseline differences between LSA coverage and revascularization groups. Long-term survival, freedom from major adverse cardiovascular events (MACE), ischemic stroke rates, and cerebrovascular accident (CVA) rates were assessed using the Kaplan-Meier analysis. Weighted logistic and Cox regression models were applied to identify predictors of short- and long-term outcomes. RESULTS: The final analysis included 253 patients. Intergroup balance was achieved after inverse probability of treatment weighting. After LSA revascularization, incidences of postoperative type II endoleak (38.9% vs 38.2%; P = .91), post implantation syndrome (38.0% vs 38.5%; P = .938), 30-day mortality (0.6% vs 1.1%; P = .568), and early CVA (0.6% vs 0.5%; P = .931) were comparable between groups. There was no significant difference in CVA incidence (4.8% vs 12.1%; P = .34) or freedom from MACE (91.2% vs 78.5%; P = .55) at 10-year follow-up. Weighted multivariable analysis identified post implantation syndrome after TEVAR as an independent predictor of CVA (hazard ratio, 2.65; 95% confidence interval, 1.10-6.42; P = .03). CONCLUSIONS: LSA revascularization during TEVAR does not increase risks for perioperative or long-term morbidities. Ischemic stroke rates, CVA rates, survival, and MACE-free survival were statistically comparable between groups at 5- and 10-year follow-up. Post implantation syndrome emerged as a significant CVA risk factor after zone 2 TEVAR for aTBAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chi…
Zitieren
APA
Cao, Z., Wu, Z., Gao, H., Zhao, K., Zhou, S., Zhang, Y., Luo, M., & Shu, C. (2025). Weighted 10-year survival and neurological outcomes after zone 2 thoracic endovascular aortic repair for acute type B aortic dissection. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.05.026
Vancouver
Cao Z, Wu Z, Gao H, Zhao K, Zhou S, Zhang Y, et al. Weighted 10-year survival and neurological outcomes after zone 2 thoracic endovascular aortic repair for acute type B aortic dissection. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.05.026
BibTeX
@article{Cao2025,
author = {Cao, Zhongze and Wu, Ziting and Gao, Huiwen and Zhao, Kexin and Zhou, Shufen and Zhang, Yahui and Luo, Mingyao and Shu, Chang},
title = {Weighted 10-year survival and neurological outcomes after zone 2 thoracic endovascular aortic repair for acute type B aortic dissection},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2025.05.026}
}
EUVIMED